Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Valeant pays $312mm for OraPharma plus potential $114mm in earn-outs

Executive Summary

Keeping up its string of acquisitions, Valeant Pharmaceuticals International Inc. is buying closely held oral health company OraPharma Inc. from private equity firm Water Street Healthcare Partners for $312mm in cash up front and up to $114mm in earn-outs based on milestones including revenue targets.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash

Related Companies